Get Level 2

Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. FLX.L Share Price
  4. FLX.L Share Regulatory News
  5. Change of Adviser

Pin to quick picksFLX.L Regulatory News (FLX)

FLX.L Information
  • There is currently no data for FLX

Change of Adviser

30 Jan 2017 07:00

RNS Number : 4126V
Falanx Group Limited
30 January 2017
 

Falanx Group Limited

("Falanx" or "the Company")

 

CHANGE OF ADVISER

 

Falanx Group (AIM:FLX), the global intelligence, security and cyber defence provider, is pleased to announce the appointment of SPARK Advisory Partners Limited as its Nominated Adviser with immediate effect.

 

 

Enquiries:

 

Falanx Group Limited

Stuart Bladen, Chief Executive

 

 

 

www.falanxgroup.com

www.falanxassuria.com

www.falanxcyberdefence.com

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis / James Keeshan

 

+44 20 3368 3551

Whitman Howard Limited

Broker

Nick Lovering / Francis North

 

+44 207 659 1234

 

About Falanx

Falanx Group Limited, is a global intelligence and cyber defence provider working with blue chip and government clients. The Group listed on AIM in June 2013 under ticker FLX For more information: http://www.falanxgroup.com/

 

MAR

This announcement contains inside information for purposes of Article 7 of Regulation (EU) No 596/2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
APPMMGZMKLVGNZM
12345
Date   Source Headline
9th Dec 20222:42 pmRNSHolding(s) in Company
8th Dec 20224:29 pmRNSResult of AGM
8th Dec 20227:00 amRNSInterim Results
24th Nov 20225:17 pmRNSHolding(s) in Company
15th Nov 20225:56 pmRNSNotice of AGM
18th Oct 20227:00 amRNSDirectorate Change
29th Sep 20227:00 amRNSFinal Results
20th Sep 20227:00 amRNSHolding(s) in Company
5th Sep 20224:53 pmRNSHolding(s) in Company
4th Aug 20222:06 pmRNSSecond Price Monitoring Extn
4th Aug 20222:00 pmRNSPrice Monitoring Extension
4th Aug 202211:05 amRNSSecond Price Monitoring Extn
4th Aug 202211:00 amRNSPrice Monitoring Extension
4th Aug 20227:00 amRNSTrading Update
9th May 20227:00 amRNSPartnership to Provide M-EDR to UK Customers
8th Apr 20224:06 pmRNSHolding(s) in Company
6th Apr 202211:59 amRNSHolding(s) in Company
1st Apr 20227:00 amRNSChange of Adviser
30th Mar 20222:44 pmRNSDirector/PDMR Shareholding
23rd Mar 202212:59 pmRNSDirector/PDMR Shareholding
10th Feb 202211:11 amRNSDirector/PDMR Shareholding
24th Jan 20227:00 amRNSDirector/PDMR Shareholding
19th Jan 20225:20 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 202111:14 amRNSResult of AGM
7th Dec 20217:00 amRNSInterim Results
16th Nov 20212:10 pmRNSNotice of AGM
29th Oct 20211:57 pmRNSExercise of Options, TVR and PDMR dealing
27th Oct 20219:03 amRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSDirector/PDMR Shareholding
25th Oct 20213:25 pmRNSExercise of Options and TVR
13th Oct 202111:06 amRNSSecond Price Monitoring Extn
13th Oct 202111:00 amRNSPrice Monitoring Extension
13th Oct 20217:00 amRNSTrading update and BOOST&Co loan facility update
6th Oct 20214:41 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
6th Oct 20212:43 pmRNSSale of Assynt for £4.6 million
4th Oct 20217:00 amRNSFalanx Launch Mass Market Security Assessment Tool
29th Sep 20217:00 amRNSAnnual results for the year ended 31 March 2021
18th Aug 20217:01 amRNSGrant of share options
18th Aug 20217:00 amRNSTrading Update & New Loan Facility
9th Jul 20219:07 amRNSHolding(s) in Company
29th Apr 20217:00 amRNSCancellation of unapproved Share Options
1st Apr 20217:00 amRNSIssue of Equity and TVR
26th Feb 20213:31 pmRNSResult of GM
10th Feb 20212:03 pmRNSPublication of Circular & Notice of GM
8th Feb 202111:05 amRNSSecond Price Monitoring Extn
8th Feb 202111:00 amRNSPrice Monitoring Extension
5th Feb 20217:00 amRNSContract Wins and Covid Business Interruption Loan
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn
12345

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
SOLG
SolGold
LSE
0.00%
EAT
European Assets Trust
LSE
0.00%
MTE
Montanaro
LSE
-0.56%
BHRD
BHRD.L
LSE
0.00%
DIG
Dunedin Inc.
LSE
-0.67%
Trending
LLOY
Lloyds
LSE
-0.77%
GST
GSTechnologies
LSE
0.00%
IMM
Immupharma
LSE
0.54%
HPOW
H-power
LSE
-2.56%
RRR
Red Rock Resources
LSE
2.17%